JW LIFESCIENCE CORPORATION Logo

JW LIFESCIENCE CORPORATION

A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.

234080 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청남도 당진시 송악읍 한진1길 28, 당진시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

JW Life Science Corporation is a leading developer and manufacturer specializing in infusion solutions. The company's core business involves producing a wide range of products, from basic intravenous (IV) fluids to complex nutrient infusion solutions that provide patients with essential amino acids, lipids, vitamins, and minerals. Operating state-of-the-art facilities like the JW Dangjin Production Complex, JW Life Science is a prominent player in its domestic market with a focus on expanding its global presence. The company is committed to advancing public health through continuous research and development, utilizing its platform technologies and research network to enhance its product pipeline and contribute to the pharmaceutical industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.2 MB
2025-08-26 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-01 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-08 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.3 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 495.7 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 21.0 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 103.0 KB
2025-02-25 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 87.7 KB
2025-02-19 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 16.1 KB
2025-02-10 00:00
Regulatory News Service
현금ㆍ현물배당결정
Korean 8.2 KB
2025-02-10 00:00
Regulatory News Service
주주총회소집결의
Korean 13.0 KB

Automate Your Workflow. Get a real-time feed of all JW LIFESCIENCE CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for JW LIFESCIENCE CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.